These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1357739)

  • 21. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical interpretation of recurrence data.
    Bynum TE
    J Clin Gastroenterol; 1987; 9 Suppl 1():31-3. PubMed ID: 3611699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists.
    Brooks WS
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():47-52. PubMed ID: 1349553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
    Driks MR; Craven DE; Celli BR; Manning M; Burke RA; Garvin GM; Kunches LM; Farber HW; Wedel SA; McCabe WR
    N Engl J Med; 1987 Nov; 317(22):1376-82. PubMed ID: 2891032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and therapy of peptic ulcer disease.
    Peterson WL
    J Clin Gastroenterol; 1990; 12 Suppl 2():S1-6. PubMed ID: 1978840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic approach to ulcer healing.
    Blum AL
    Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of sucralfate versus cimetidine in the treatment of acute gastroduodenal ulcer. Randomized trial with 667 patients.
    Rey JF; Legras B; Verdier A; Vicari F; Gorget C
    Am J Med; 1989 Jun; 86(6A):116-21. PubMed ID: 2660553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer].
    Di Mario F; Gottardello L; Burra P; Salvagnini M; Dalrì L; Leandro G; Contento F; Torri A; Naccarato R
    G Clin Med; 1990 Apr; 71(4):259-62, 265-6. PubMed ID: 1973392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of ulcer disease].
    Loizeau E
    Schweiz Med Wochenschr; 1986 Oct; 116(40):1371-4. PubMed ID: 2877491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins, H2-receptor antagonists and peptic ulcer disease.
    Bright-Asare P; Habte T; Yirgou B; Benjamin J
    Drugs; 1988; 35 Suppl 3():1-9. PubMed ID: 2905237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate.
    Tryba M
    Crit Care Med; 1991 Jul; 19(7):942-9. PubMed ID: 1675976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of duodenal ulcer recurrence.
    Strum WB
    Ann Intern Med; 1986 Nov; 105(5):757-61. PubMed ID: 2876669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
    Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.